Biberach, Germany

Gebhard Adelgoss


Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gebhard Adelgoss

Introduction

Gebhard Adelgoss, a notable inventor hailing from Biberach, Germany, has made significant contributions to the field of medicinal chemistry. With a total of four patents to his name, Adelgoss has focused his research on compounds that hold the potential for therapeutic applications. His work reflects a commitment to innovation within the pharmaceutical industry.

Latest Patents

Adelgoss's latest patents include a breakthrough invention: a crystalline form of 1'-(1-methylethyl)-4'–[(2-fluoro-4-methoxyphenyl)methyl]-5'–methyl-1H-pyrazol-3'–O-β-D-glucopyranoside. This invention encompasses not only the crystalline form itself but also a method for its preparation and its use in developing medicaments. The implications of this work suggest the potential for new treatments that could emerge from his findings.

Career Highlights

Throughout his career, Gebhard Adelgoss has worked with prominent companies in the pharmaceutical industry, including Ajinomoto Co., Ltd. and Boehringer Ingelheim Pharma KG. His experience at these organizations has allowed him to refine his skills in research and development, contributing to the creation of innovative pharmaceutical products.

Collaborations

During his tenure in the industry, Adelgoss has had the opportunity to work alongside esteemed colleagues, such as Gebhard Schilcher and Gerd Kraemer. These collaborations have likely enriched his research endeavors and fostered an environment of shared knowledge and expertise, further advancing the field of medicinal chemistry.

Conclusion

In summary, Gebhard Adelgoss stands out as an influential figure in the realm of pharmaceutical innovation. His patents, especially the latest pertaining to 1'-(1-methylethyl)-4'–[(2-fluoro-4-methoxyphenyl)methyl]-5'–methyl-1H-pyrazol-3'–O-β-D-glucopyranoside, illustrate his dedication to developing effective medicaments. With a robust career aided by meaningful collaborations, Adelgoss continues to impact the pharmaceutical landscape significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…